KRMD
KORU Medical Systems, Inc.NASDAQHealthcareAs of 2026-04-06
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
11.70
P/S
4.87
EV/EBITDA
-94.07
DCF Value
$-10.73
FCF Yield
-0.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
60.3%
Operating Margin
-6.7%
Net Margin
-6.4%
ROE
-15.9%
ROA
-9.6%
ROIC
-13.5%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $10.9M | $-486.9K | $-0.01 |
| FY 2025 | $41.1M | $-2.6M | $-0.06 |
| Q3 2025 | $10.4M | $-778.0K | $-0.02 |
| Q2 2025 | $10.2M | $-206.9K | $-0.00 |
Analyst Ratings
View AllTrading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NASDAQ
Beta
0.54
KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. It offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company also provides education and training materials to clinicians, patients, and patient advocates. It sells its products through direct sales and medical device distributors, as well as online. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Chester, New York.